Selected research
Market Analysis & Forecast
Global Poultry Medicine and Vaccines Market Analysis and Forecast 2026-2032
Market perspective
The global Poultry Medicine and Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Poultry Medicine and Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Poultry Medicine and Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Poultry Medicine and Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Poultry Medicine and Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Poultry Medicine and Vaccines include Zoetis, Yebio, Vaksindo, Ringpu Biology, QYH Biotech, Merial, Merck Animal Health, Harbin Veterinary Research Institute and FATRO, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Poultry Medicine and Vaccines, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Poultry Medicine and Vaccines, also provides the revenue of main regions and countries. Of the upcoming market potential for Poultry Medicine and Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Poultry Medicine and Vaccines revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Poultry Medicine and Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Poultry Medicine and Vaccines revenue, projected growth trends, production technology, application and end-user industry.
Poultry Medicine and Vaccines Segment by Company
Zoetis
Yebio
Vaksindo
Ringpu Biology
QYH Biotech
Merial
Merck Animal Health
Harbin Veterinary Research Institute
FATRO
Elanco (Lohmann)
DHN
ChengDu Tecbond
CEVA
CAVAC
Poultry Medicine and Vaccines Segment by Type
Medicine
Vaccines
Poultry Medicine and Vaccines Segment by Application
Chicken
Duck
Other
Poultry Medicine and Vaccines Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Poultry Medicine and Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Poultry Medicine and Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Poultry Medicine and Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Poultry Medicine and Vaccines in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Poultry Medicine and Vaccines company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Poultry Medicine and Vaccines revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Medicine
- Vaccines
Applications
- Chicken
- Duck
- Other
Companies covered
- Zoetis
- Yebio
- Vaksindo
- Ringpu Biology
- QYH Biotech
- Merial
- Merck Animal Health
- Harbin Veterinary Research Institute
- FATRO
- Elanco (Lohmann)
- DHN
- ChengDu Tecbond
- CEVA
- CAVAC
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Poultry Medicine and Vaccines Market by Type
- 1.2.1 Global Poultry Medicine and Vaccines Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Medicine
- 1.2.3 Vaccines
- 1.3 Poultry Medicine and Vaccines Market by Application
- 1.3.1 Global Poultry Medicine and Vaccines Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Chicken
- 1.3.3 Duck
- 1.3.4 Other
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Poultry Medicine and Vaccines Market Dynamics
- 2.1 Poultry Medicine and Vaccines Industry Trends
- 2.2 Poultry Medicine and Vaccines Industry Drivers
- 2.3 Poultry Medicine and Vaccines Industry Opportunities and Challenges
- 2.4 Poultry Medicine and Vaccines Industry Restraints
3 Global Growth Perspective
- 3.1 Global Poultry Medicine and Vaccines Market Perspective (2021-2032)
- 3.2 Global Poultry Medicine and Vaccines Growth Trends by Region
- 3.2.1 Global Poultry Medicine and Vaccines Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Poultry Medicine and Vaccines Market Size by Region (2021-2026)
- 3.2.3 Global Poultry Medicine and Vaccines Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Poultry Medicine and Vaccines Revenue by Players
- 4.1.1 Global Poultry Medicine and Vaccines Revenue by Players (2021-2026)
- 4.1.2 Global Poultry Medicine and Vaccines Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Poultry Medicine and Vaccines Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Poultry Medicine and Vaccines Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Poultry Medicine and Vaccines Key Players Headquarters & Area Served
- 4.4 Global Poultry Medicine and Vaccines Players, Product Type & Application
- 4.5 Global Poultry Medicine and Vaccines Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Poultry Medicine and Vaccines Market CR5 and HHI
- 4.6.3 2025 Poultry Medicine and Vaccines Tier 1, Tier 2, and Tier 3
5 Poultry Medicine and Vaccines Market Size by Type
- 5.1 Global Poultry Medicine and Vaccines Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Poultry Medicine and Vaccines Revenue by Type (2021-2032)
- 5.3 Global Poultry Medicine and Vaccines Revenue Market Share by Type (2021-2032)
6 Poultry Medicine and Vaccines Market Size by Application
- 6.1 Global Poultry Medicine and Vaccines Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Poultry Medicine and Vaccines Revenue by Application (2021-2032)
- 6.3 Global Poultry Medicine and Vaccines Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Zoetis
- 7.1.1 Zoetis Company Information
- 7.1.2 Zoetis Business Overview
- 7.1.3 Zoetis Poultry Medicine and Vaccines Revenue and Gross Margin (2021-2026)
- 7.1.4 Zoetis Poultry Medicine and Vaccines Product Portfolio
- 7.1.5 Zoetis Recent Developments
- 7.2 Yebio
- 7.2.1 Yebio Company Information
- 7.2.2 Yebio Business Overview
- 7.2.3 Yebio Poultry Medicine and Vaccines Revenue and Gross Margin (2021-2026)
- 7.2.4 Yebio Poultry Medicine and Vaccines Product Portfolio
- 7.2.5 Yebio Recent Developments
- 7.3 Vaksindo
- 7.3.1 Vaksindo Company Information
- 7.3.2 Vaksindo Business Overview
- 7.3.3 Vaksindo Poultry Medicine and Vaccines Revenue and Gross Margin (2021-2026)
- 7.3.4 Vaksindo Poultry Medicine and Vaccines Product Portfolio
- 7.3.5 Vaksindo Recent Developments
- 7.4 Ringpu Biology
- 7.4.1 Ringpu Biology Company Information
- 7.4.2 Ringpu Biology Business Overview
- 7.4.3 Ringpu Biology Poultry Medicine and Vaccines Revenue and Gross Margin (2021-2026)
- 7.4.4 Ringpu Biology Poultry Medicine and Vaccines Product Portfolio
- 7.4.5 Ringpu Biology Recent Developments
- 7.5 QYH Biotech
- 7.5.1 QYH Biotech Company Information
- 7.5.2 QYH Biotech Business Overview
- 7.5.3 QYH Biotech Poultry Medicine and Vaccines Revenue and Gross Margin (2021-2026)
- 7.5.4 QYH Biotech Poultry Medicine and Vaccines Product Portfolio
- 7.5.5 QYH Biotech Recent Developments
- 7.6 Merial
- 7.6.1 Merial Company Information
- 7.6.2 Merial Business Overview
- 7.6.3 Merial Poultry Medicine and Vaccines Revenue and Gross Margin (2021-2026)
- 7.6.4 Merial Poultry Medicine and Vaccines Product Portfolio
- 7.6.5 Merial Recent Developments
- 7.7 Merck Animal Health
- 7.7.1 Merck Animal Health Company Information
- 7.7.2 Merck Animal Health Business Overview
- 7.7.3 Merck Animal Health Poultry Medicine and Vaccines Revenue and Gross Margin (2021-2026)
- 7.7.4 Merck Animal Health Poultry Medicine and Vaccines Product Portfolio
- 7.7.5 Merck Animal Health Recent Developments
- 7.8 Harbin Veterinary Research Institute
- 7.8.1 Harbin Veterinary Research Institute Company Information
- 7.8.2 Harbin Veterinary Research Institute Business Overview
- 7.8.3 Harbin Veterinary Research Institute Poultry Medicine and Vaccines Revenue and Gross Margin (2021-2026)
- 7.8.4 Harbin Veterinary Research Institute Poultry Medicine and Vaccines Product Portfolio
- 7.8.5 Harbin Veterinary Research Institute Recent Developments
- 7.9 FATRO
- 7.9.1 FATRO Company Information
- 7.9.2 FATRO Business Overview
- 7.9.3 FATRO Poultry Medicine and Vaccines Revenue and Gross Margin (2021-2026)
- 7.9.4 FATRO Poultry Medicine and Vaccines Product Portfolio
- 7.9.5 FATRO Recent Developments
- 7.10 Elanco (Lohmann)
- 7.10.1 Elanco (Lohmann) Company Information
- 7.10.2 Elanco (Lohmann) Business Overview
- 7.10.3 Elanco (Lohmann) Poultry Medicine and Vaccines Revenue and Gross Margin (2021-2026)
- 7.10.4 Elanco (Lohmann) Poultry Medicine and Vaccines Product Portfolio
- 7.10.5 Elanco (Lohmann) Recent Developments
- 7.11 DHN
- 7.11.1 DHN Company Information
- 7.11.2 DHN Business Overview
- 7.11.3 DHN Poultry Medicine and Vaccines Revenue and Gross Margin (2021-2026)
- 7.11.4 DHN Poultry Medicine and Vaccines Product Portfolio
- 7.11.5 DHN Recent Developments
- 7.12 ChengDu Tecbond
- 7.12.1 ChengDu Tecbond Company Information
- 7.12.2 ChengDu Tecbond Business Overview
- 7.12.3 ChengDu Tecbond Poultry Medicine and Vaccines Revenue and Gross Margin (2021-2026)
- 7.12.4 ChengDu Tecbond Poultry Medicine and Vaccines Product Portfolio
- 7.12.5 ChengDu Tecbond Recent Developments
- 7.13 CEVA
- 7.13.1 CEVA Company Information
- 7.13.2 CEVA Business Overview
- 7.13.3 CEVA Poultry Medicine and Vaccines Revenue and Gross Margin (2021-2026)
- 7.13.4 CEVA Poultry Medicine and Vaccines Product Portfolio
- 7.13.5 CEVA Recent Developments
- 7.14 CAVAC
- 7.14.1 CAVAC Company Information
- 7.14.2 CAVAC Business Overview
- 7.14.3 CAVAC Poultry Medicine and Vaccines Revenue and Gross Margin (2021-2026)
- 7.14.4 CAVAC Poultry Medicine and Vaccines Product Portfolio
- 7.14.5 CAVAC Recent Developments
8 North America
- 8.1 North America Poultry Medicine and Vaccines Revenue (2021-2032)
- 8.2 North America Poultry Medicine and Vaccines Revenue by Type (2021-2032)
- 8.2.1 North America Poultry Medicine and Vaccines Revenue by Type (2021-2026)
- 8.2.2 North America Poultry Medicine and Vaccines Revenue by Type (2027-2032)
- 8.3 North America Poultry Medicine and Vaccines Revenue Share by Type (2021-2032)
- 8.4 North America Poultry Medicine and Vaccines Revenue by Application (2021-2032)
- 8.4.1 North America Poultry Medicine and Vaccines Revenue by Application (2021-2026)
- 8.4.2 North America Poultry Medicine and Vaccines Revenue by Application (2027-2032)
- 8.5 North America Poultry Medicine and Vaccines Revenue Share by Application (2021-2032)
- 8.6 North America Poultry Medicine and Vaccines Revenue by Country
- 8.6.1 North America Poultry Medicine and Vaccines Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Poultry Medicine and Vaccines Revenue by Country (2021-2026)
- 8.6.3 North America Poultry Medicine and Vaccines Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
9 Europe
- 9.1 Europe Poultry Medicine and Vaccines Revenue (2021-2032)
- 9.2 Europe Poultry Medicine and Vaccines Revenue by Type (2021-2032)
- 9.2.1 Europe Poultry Medicine and Vaccines Revenue by Type (2021-2026)
- 9.2.2 Europe Poultry Medicine and Vaccines Revenue by Type (2027-2032)
- 9.3 Europe Poultry Medicine and Vaccines Revenue Share by Type (2021-2032)
- 9.4 Europe Poultry Medicine and Vaccines Revenue by Application (2021-2032)
- 9.4.1 Europe Poultry Medicine and Vaccines Revenue by Application (2021-2026)
- 9.4.2 Europe Poultry Medicine and Vaccines Revenue by Application (2027-2032)
- 9.5 Europe Poultry Medicine and Vaccines Revenue Share by Application (2021-2032)
- 9.6 Europe Poultry Medicine and Vaccines Revenue by Country
- 9.6.1 Europe Poultry Medicine and Vaccines Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Poultry Medicine and Vaccines Revenue by Country (2021-2026)
- 9.6.3 Europe Poultry Medicine and Vaccines Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Netherlands
10 China
- 10.1 China Poultry Medicine and Vaccines Revenue (2021-2032)
- 10.2 China Poultry Medicine and Vaccines Revenue by Type (2021-2032)
- 10.2.1 China Poultry Medicine and Vaccines Revenue by Type (2021-2026)
- 10.2.2 China Poultry Medicine and Vaccines Revenue by Type (2027-2032)
- 10.3 China Poultry Medicine and Vaccines Revenue Share by Type (2021-2032)
- 10.4 China Poultry Medicine and Vaccines Revenue by Application (2021-2032)
- 10.4.1 China Poultry Medicine and Vaccines Revenue by Application (2021-2026)
- 10.4.2 China Poultry Medicine and Vaccines Revenue by Application (2027-2032)
- 10.5 China Poultry Medicine and Vaccines Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Poultry Medicine and Vaccines Revenue (2021-2032)
- 11.2 Asia Poultry Medicine and Vaccines Revenue by Type (2021-2032)
- 11.2.1 Asia Poultry Medicine and Vaccines Revenue by Type (2021-2026)
- 11.2.2 Asia Poultry Medicine and Vaccines Revenue by Type (2027-2032)
- 11.3 Asia Poultry Medicine and Vaccines Revenue Share by Type (2021-2032)
- 11.4 Asia Poultry Medicine and Vaccines Revenue by Application (2021-2032)
- 11.4.1 Asia Poultry Medicine and Vaccines Revenue by Application (2021-2026)
- 11.4.2 Asia Poultry Medicine and Vaccines Revenue by Application (2027-2032)
- 11.5 Asia Poultry Medicine and Vaccines Revenue Share by Application (2021-2032)
- 11.6 Asia Poultry Medicine and Vaccines Revenue by Country
- 11.6.1 Asia Poultry Medicine and Vaccines Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Poultry Medicine and Vaccines Revenue by Country (2021-2026)
- 11.6.3 Asia Poultry Medicine and Vaccines Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Poultry Medicine and Vaccines Revenue (2021-2032)
- 12.2 SAMEA Poultry Medicine and Vaccines Revenue by Type (2021-2032)
- 12.2.1 SAMEA Poultry Medicine and Vaccines Revenue by Type (2021-2026)
- 12.2.2 SAMEA Poultry Medicine and Vaccines Revenue by Type (2027-2032)
- 12.3 SAMEA Poultry Medicine and Vaccines Revenue Share by Type (2021-2032)
- 12.4 SAMEA Poultry Medicine and Vaccines Revenue by Application (2021-2032)
- 12.4.1 SAMEA Poultry Medicine and Vaccines Revenue by Application (2021-2026)
- 12.4.2 SAMEA Poultry Medicine and Vaccines Revenue by Application (2027-2032)
- 12.5 SAMEA Poultry Medicine and Vaccines Revenue Share by Application (2021-2032)
- 12.6 SAMEA Poultry Medicine and Vaccines Revenue by Country
- 12.6.1 SAMEA Poultry Medicine and Vaccines Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Poultry Medicine and Vaccines Revenue by Country (2021-2026)
- 12.6.3 SAMEA Poultry Medicine and Vaccines Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst